𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anaemia and red blood cell transfusion in the critically ill patient

✍ Scribed by S.A. McLellan; D.B.L. McClelland; T.S. Walsh


Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
169 KB
Volume
17
Category
Article
ISSN
0268-960X

No coin nor oath required. For personal study only.

✦ Synopsis


Anaemia is a common finding in critically ill patients. There are often multiple causes. Obvious causes include surgical bleeding and gastrointestinal haemorrhage but many patients have no overt bleeding episodes. Phlebotomy can be a significant source of blood loss. In addition, critically ill patients have impaired erythropoiesis as a consequence of blunted erythropoietin production and direct inhibitory effects of inflammatory cytokines. The ability of a patient to tolerate anaemia depends on their clinical condition and the presence of any significant co-morbidity; maintenance of circulating volume is of paramount importance. There is no universal transfusion trigger. Current guidelines for critically ill and perioperative patients advise that at Hb values <70 g/L red blood cell transfusion is strongly indicated and at Hb values >100 g/L transfusion is unjustified. For patients with Hb values in the range 70 to 100 g/L the transfusion trigger should be based on clinical indicators. Most stable critically ill patients can probably be managed with a Hb concentration between 70 and 90 g/L. Uncertainties exist concerning the most appropriate Hb concentration for patients with significant cardio-respiratory disease.


πŸ“œ SIMILAR VOLUMES


Red blood cell transfusions and iron ove
✍ Elias Jabbour; Hagop M. Kantarjian; Charles Koller; Ali Taher πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 185 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Approximately 15,000 new cases of myelodysplastic syndromes (MDS) are expected in the United States each year. ## METHODS The mainstay for the management of myelodysplastic syndromes (MDS) is supportive therapy with red blood cell (RBC) transfusions to improve the patie

Transfusion intensity, not the cumulativ
✍ Arturo Pereira; Meritxell Nomdedeu; Josep-LluΓ­s Aguilar; Mohamed Belkaid; Anna C πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 255 KB

## Abstract Transfusion‐dependency is associated with poor prognosis in patients with MDS although the causal link for such association is disputed. This study tests thee hypotheses on the association between transfusion burden and prognosis in the MDS: (1) the cumulative transfusion burden is a co

A survey of physicians' attitudes to tra
✍ Harsha Boralessa; M. P. Rao; C. Morgan; N. Soni; D. R. Goldhill; S. J. Brett; Ha πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 469 KB

**Summary** We performed a postal survey of Fellows of the Australian and New Zealand College of Anaesthetists with a special interest in obstetric practice, about their beliefs regarding aseptic precautions for insertion of an epidural catheter in the labour ward. Of the 435 consultant anaesthetist

Improved survival in red blood cell tran
✍ Heather A. Leitch; Jocelyn M. Chase; Trisha A. Goodman; Hatoon Ezzat; Meaghan D. πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 173 KB

## Abstract Many patients with primary myelofibrosis (PMF) become red blood cell (RBC) transfusion dependent (TD), risking iron overload (IOL). Iron chelation therapy (ICT) may decrease the risk of haemosiderosis associated organ dysfunction, though its benefit in PMF is undefined. To assess the ef